Mark Cuban - 'Shark Tank' and Cost Plus Drugs | The Daily Show
Mark Cuban discusses the legacy of "Shark Tank," his unique perspective as an NBA fan and Dallas Mavericks owner and disrupting the...
News
- Oct 18
Prescription drug pricing reform must rein in pharmacy benefit managers
This month, President Biden signed an executive order directing federal health departments to create plans within 90 days to lower...
- Oct 17
U.S. sues Cigna Corp for overcharging Medicare Advantage program
U.S. prosecutors in Manhattan said on Monday they filed a civil lawsuit against Cigna Corp (CI.N) accusing the health insurer of...
- Oct 13
Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, & Providers: A 2022 Update
I conservatively estimate that I’ve created about 1,374,613 slides during my career. But there are two slides that people seem to...
- Oct 12
Opinion: Reforms will lower prescription drug costs for patients and taxpayers
In a win for Texas taxpayers, the state government recently secured $165 million in a lawsuit alleging that the pharmacy benefit manager...
- Oct 11
Medicare Advantage gets exploited by insurers
Insurers have been employing lucrative strategies to milk more money from the federal Medicare Advantage program than they may legally be...
- Oct 4
PBM Accountability Project Managing Director Mark Blum Joins Pharmacy Podcast Network
Today we are hoping to make sense of the Inflation Reduction Act which is designed to protect Medicare recipients from catastrophic drug...
- Oct 4
War over drug-cost assistance traps sickest patients in the middle
When Mike Gartner was shopping for health-insurance coverage early this year, he did his homework. Gartner, a software engineer in...
- Oct 4
FTC examining options for PBM regulation
The Federal Trade Commission is considering all its tools, including law enforcement or market-wide rulemaking, as it scrutinizes the...
- Sep 30
Antitrust regulator takes aim at drug middlemen
The newest member of the Federal Trade Commission last week said that for decades his agency hasn’t served the historical mission of the...
- Sep 29
Centene Agrees to Pay Massachusetts $14 Million Over Medicaid Prescription Claims
Massachusetts has become the latest state to settle with health insurance giant Centene Corp. over allegations that it overbilled the...
- Sep 27
Time to Rein in the Drug-Industry Middlemen Exploiting Patients
Last month, lawmakers missed a big chance to lower the cost of prescription medicine. Despite including a host of new drug-pricing...
- Sep 26
The Middleman Mentality Is Killing American Medicine
Between producers and consumers, you’ll find a cadre of professionals who broker deals, facilitate transactions, and move goods and...
- Sep 23
Consolidation in US health care negatively impacts cancer care
Consolidation in the US health-care sector has been rising over the past two decades, with mergers and acquisitions of national players...
- Sep 19
Centene agrees to pay Texas $166 million in Medicaid drug pricing settlement
Health insurance giant Centene Corp. has agreed to pay $165.6 million to Texas to resolve claims that it overcharged the state’s Medicaid...
- Aug 31
Patient groups sue HHS over co-pay assistance program
Groups representing HIV and diabetes patients are trying to scrap a Medicare rule they say leaves sick patients stuck with higher drug...
- Aug 30
Pharmacy Middlemen Deserve Reformers' Attention
Drug pricing reform has received renewed attention in recent months, but one entity always seems to escape unscathed in reform efforts:...
- Aug 24
Centene to pay $33.3 mln to settle Washington Medicaid fraud claims
Managed care giant Centene Corp has agreed to pay $33.3 million to resolve claims that it overcharged Apple Health, Washington state's...
- Aug 23
From Meat to Insulin, How the Middlemen Economy Makes Everything More Expensive
The Federal Trade Commission recently launched an inquiry into the practices of pharmacy benefit managers, known in the industry as PBMs....
- Aug 19
Frustrated pharmacists are opting out of the insurance system, saving some customers hundreds...
A small but growing number of "cash" pharmacies take no insurance, instead selling generic drugs, often at far lower prices than...